BioSpace News Archive

10 Quick Hacks That Will Ease Your Fear of Public Speaking in the Workplace

Glossophobia, or the fear of public speaking, can range in severity from mildly disruptive anxiety to a full-fledged disorder. Here’s how you can handle it.

March 21, 2018
·
7 min read
Genetown

TCR2 Therapeutics Snags $125 Million To Expand T-Cell Program

TCR2 Therapeutics has raised $125 million in Series B financing to advance two T-Cell receptor (TCR) programs through clinical proof-of-concept.

March 21, 2018
·
2 min read
·
Alex Keown
Business

Alder CEO Is Stepping Down

Alder BioPharmaceuticals announced that Randall Schatzman, the company’s president, chief executive officer and director, will be stepping down.

March 21, 2018
·
3 min read
·
Mark Terry
Business

Celgene Partners with Prothena Therapeutics in Potential $2B Deal

Prothena Therapeutics has forged a collaboration with Celgene worth a potential $2B to develop new therapies for a broad range of neurodegenerative diseases.

March 21, 2018
·
2 min read
·
Alex Keown
Business

GlaxoSmithKline: Helping people do more, feel better, live longer

In BioSpace’s Ideal Employer Survey GSK came in at #12 overall in the survey rankings.

March 21, 2018
·
2 min read
·
Shaeffer Smith and Alex Keown
Pharm Country

GlaxoSmithKline Is Taking a Tough Approach to Budgets

The head of GlaxoSmithKline’s pharmaceuticals division is pushing to cut its budget by 20 percent.

March 21, 2018
·
2 min read
·
Mark Terry
Genetown

Is There a Biotech Bubble Brewing in Boston?

Billions of dollars are being invested in Boston-based life science companies.

March 21, 2018
·
2 min read
·
Alex Keown
FDA

Seattle Genetics Gains Another FDA Approval

Seattle Genetics announced today that the FDA has granted approval for its Adcetris drug to treat Hodgkins Lymphoma.

March 21, 2018
·
3 min read
·
Mark Terry
Drug Development

Cidara Therapeutics Reports Positive Topline Results from Phase 2 STRIVE Trial of Lead Antifungal Rezafungin

Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported positive topline results from the global, randomized Phase 2 STRIVE clinical trial of its lead antifungal candidate rezafungin acetate.

March 21, 2018
·
11 min read
Biotech Beach

Neuropathy Action Foundation Announces 12th Annual “Neuropathy Action Awareness Day, “Largest Neuropathy-Related Patient Event In The United States

Registration Now Open for LA-Area Event Dedicated to Raising Awareness of Neuropathy

March 21, 2018
·
2 min read